Cystatin C Is Downregulated in Prostate Cancer and Modulates Invasion of Prostate Cancer Cells via MAPK/Erk and Androgen Receptor Pathways

• Barbara Wegiel,

  Affiliations Department of Clinical Sciences, Division of Urological Cancers, Clinical Research Center, University Hospital Malmö, Lund University, Malmö, Sweden, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Thomas Jiborn,

  Affiliation Department of Clinical Sciences, Division of Urological Cancers, Clinical Research Center, University Hospital Malmö, Lund University, Malmö, Sweden

  ⨯
• Magnus Abrahamson,

  Affiliation Department of Laboratory Medicine, Division of Clinical Chemistry and Pharmacology, Lund University Hospital, Lund University, Lund, Sweden

  ⨯
• Leszek Helczynski,

  Affiliation Department of Pathology, Clinical Research Center, University Hospital Malmö, Lund University, Malmö, Sweden

  ⨯
• Leo Otterbein,

  Affiliation Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Jenny Liao Persson ,

  Contributed equally to this work with: Jenny Liao Persson, Anders Bjartell

  * E-mail: jenny_l.persson@med.lu.se

  Affiliation Department of Laboratory Medicine, Clinical Research Center, University Hospital Malmö, Lund University, Malmö, Sweden

  ⨯
• Anders Bjartell

  Contributed equally to this work with: Jenny Liao Persson, Anders Bjartell

  Affiliation Department of Clinical Sciences, Division of Urological Cancers, Clinical Research Center, University Hospital Malmö, Lund University, Malmö, Sweden

  ⨯